Clover Leaf Capital (CLOE)
Search documents
Clover Leaf Capital (CLOE) - 2024 Q2 - Quarterly Report
2024-08-15 20:10
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended June 30, 2024 or ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File Number: 001-40625 | --- | --- | |---------------------------------------------------------------------------------------|------------------- ...
DIGITAL ALLY, INC ANNOUNCES FIST QUARTER 2024 OPERATING RESULTS
Newsfilter· 2024-05-20 20:15
LENEXA, Kansas, May 20, 2024 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ:DGLY) (the "Company" or "our"), today announced its operating results for the first quarter of 2024. An investor conference call is scheduled for 11:15 a.m. EDT on Tuesday, May 21, 2024 (see details below). Highlights for the first quarter ended March 31, 2024 ● Overall gross profits for the three months ended March 31, 2024 were $1,523,699, a slight decrease of $21,093, or 1%, as compared to $1,544,792 for the three months ended Ma ...
Clover Leaf Capital (CLOE) - 2024 Q1 - Quarterly Report
2024-05-15 20:50
As of March 31, 2024, and December 31, 2023, the Company's investments were held in the Trust Account are held in an interestbearing demand deposit account and are classified as trading securities. Trading securities are presented on the balance sheets at fair value at the end of each reporting period. Gains and losses resulting from the change in fair value of investments held in Trust Account are included in interest earned on marketable securities held in Trust Account in the accompanying statements of o ...
DIGITAL ALLY, INC ANNOUNCES 2023 OPERATING RESULTS
Newsfilter· 2024-04-02 12:10
LENEXA, Kansas, April 02, 2024 (GLOBE NEWSWIRE) -- Digital Ally, Inc. (NASDAQ:DGLY) (the "Company" or "our"), today announced its operating results for fiscal year 2023. An investor conference call is scheduled for 11:15 a.m. EDT on Tuesday, April 2, 2024 (see details below). Highlights for the year ended December 31, 2023 ●Overall gross profits for the year ended December 31, 2023 were $5,762,484, an increase of $3,440,543, or 148%, as compared to $2,321,941 for the year ended December 31, 2022. The overal ...
Clover Leaf Capital (CLOE) - 2023 Q4 - Annual Report
2024-03-21 23:26
● Opportunities for Add-On Acquisitions. We seek to acquire one or more businesses that we can grow both organically and through acquisitions. In addition, we believe that our ability to source proprietary opportunities and execute such transactions will help the business we acquire grow through acquisition, and thus serve as a platform for further addon acquisitions. These criteria are not intended to be exhaustive. Any evaluation relating to the merits of a particular initial business combination may be b ...
Clover Leaf Capital (CLOE) - 2023 Q3 - Quarterly Report
2023-11-13 16:00
On July 18, 2022, the Company issued a promissory note (the "First Extension Note") in the principal amount of $1,383,123 to the Sponsor in connection with the extension of the Combination Period from July 22, 2022 to October 22, 2022 (the "First Extension"). On October 19, 2022, the Company held a special meeting of stockholders (the "Second Extension Meeting"). At the Second Extension Meeting, the Company's stockholders approved an amendment to the Company's amended and restated certificate of incorporati ...
Clover Leaf Capital (CLOE) - 2023 Q2 - Quarterly Report
2023-08-13 16:00
Representative's Common Stock The Company agreed to issue to Maxim and/or its designees, 125,000 shares of common stock (or 143,750 shares if the underwriter's over-allotment option is exercised in full) upon the consummation of the IPO. On July 22, 2021, the underwriters partially exercised their over-allotment option, resulting in an aggregate issuance of 138,312 representative shares. These shares were valued at a price of $10.00 which was the sale price of the units sold in the IPO. Maxim has agreed not ...
Clover Leaf Capital (CLOE) - 2023 Q1 - Quarterly Report
2023-05-15 16:00
In addition, in order to finance transaction costs in connection with a Business Combination, the Company's Sponsor or an affiliate of the Sponsor or certain of the Company's officers and directors may, but are not obligated to, provide the Company Working Capital Loans, as defined below (see Note 5). As of March 31, 2023 and December 31, 2022, there were no amounts outstanding under any Working Capital Loans. Until the consummation of a Business Combination, the Company will be using the funds not held in ...
Clover Leaf Capital (CLOE) - 2022 Q4 - Annual Report
2023-04-13 16:00
Our sponsor, officers and directors have entered into a letter agreement with us, pursuant to which they have waived their rights to liquidating distributions from the trust account with respect to any founder shares and private placement shares held by them if we fail to complete our initial business combination by July 22, 2023. However, if our sponsor, officers or directors acquire public shares, they will be entitled to liquidating distributions from the trust account with respect to such public shares ...
Clover Leaf Capital (CLOE) - 2022 Q3 - Quarterly Report
2022-11-13 16:00
UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q (Mark One) ☒ QUARTERLY REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the quarterly period ended September 30, 2022 ☐ TRANSITION REPORT PURSUANT TO SECTION 13 OR 15(d) OF THE SECURITIES EXCHANGE ACT OF 1934 For the transition period from to Commission File No. 001-40625 CLOVER LEAF CAPITAL CORP. (Exact name of registrant as specified in its charter) Delaware 86-2303279 (State or other jurisdi ...